Cleerly, Inc.
USPTO PatentsView assignee record - 62 granted patents across 7 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Cleerly ranks #5,507 of 49,997 tracked US assignees by granted-patent volume, with 62 patents across 7 technology areas.
- #5,507
- of 49,997 US assignees by volume
- Top 4%
- by Innovation Score (58.7/100)
- 26.4
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R5507 · US Corporation #5,507 · 62 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-SMALL 62 grants
- UPPER-Q #5,507/49,997
- PHOTO-FINISH Caavo
- CPC-NARROW A61B · 7 areas
- INNOV-PAR 58.7/100
- CLAIMS-DENSE 26.4 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Caavo Inc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Cleerly’s 58.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Cleerly
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Deepx · near
Deepx · near
59 score
- Nippon Sheet Glass · near
Nippon Sheet Glass · near
59 score
- Voith Patent · near
Voith Patent · near
59 score
- Cleerly · this assignee
Cleerly · this assignee
59 score
- Nanjing Tech… · near
Nanjing Tech… · near
59 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Cleerly's Innovation Score is 58.7/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Cleerly?
Each dot is one of Cleerly’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cleerly’s own 26.4 claims/patent is ABOVE the 17.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Cleerly's grants concentrate
Cleerly, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (15 grants) versus a trough of 1 in 2020. By volume, Cleerly sits between C/HCA, Inc. and Exelixis, Inc..
Cleerly's three-year grant acceleration
Cleerly, Inc. shows 45 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Cleerly's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- C/HCA
C/HCA, Inc.
62 patents
- Chemtreat
Chemtreat, Inc.
62 patents
- Caavo
Caavo Inc
62 patents
- Cephea Valve
Cephea Valve Technologies, Inc.
62 patents
- Dspace
Dspace GMBH
62 patents
- Egnyte
Egnyte, Inc.
62 patents
- Evident
Evident Corporation
62 patents
- Exelixis
Exelixis, Inc.
62 patents
- Cleerly ◀
Cleerly, Inc.
62 patents
What this shows Cleerly holds 62 patents at rank #5,507, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Cleerly
By rank, the assignees closest to #5,507 in granted patent volume.
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Cleerly's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Cleerly, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Cleerly ranks #297 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (59 here).
Similar claim depth
Nearest assignees by average claims per patent (26.4 here).
Cleerly's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
59 Top 4% higher than 96% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 1.6% |
| 2021 | 7 | 11.3% |
| 2022 | 15 | 24.2% |
| 2023 | 15 | 24.2% |
| 2024 | 15 | 24.2% |
| 2025partial year | 9 | 14.5% |
Which technologies does Cleerly, Inc. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Cleerly, Inc.'s patent record in context - here's where to go next.
- Cleerly, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #5,507 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Cleerly, Inc. against C/HCA, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 58.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.